Next Article in Journal
A Study of Factors Contributing to the Nutritional Status of Elderly People Receiving Home Care
Previous Article in Journal
The Role of Secreted Frizzled-Related Protein 5 (Sfrp5) in Overweight and Obesity in Childhood and Adolescence
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Effect of Dietary Types on Gut Microbiota Composition and Development of Non-Communicable Diseases: A Narrative Review

Institute of Hygiene, Faculty of Medicine, Comenius University in Bratislava, Špitálska 24, 813 72 Bratislava, Slovakia
*
Author to whom correspondence should be addressed.
Nutrients 2024, 16(18), 3134; https://doi.org/10.3390/nu16183134
Submission received: 26 July 2024 / Revised: 14 September 2024 / Accepted: 15 September 2024 / Published: 17 September 2024
(This article belongs to the Special Issue The Role of Preventive Nutrition in Cardio-Metabolic Disease)

Abstract

:
Introduction: The importance of diet in shaping the gut microbiota is well established and may help improve an individual’s overall health. Many other factors, such as genetics, age, exercise, antibiotic therapy, or tobacco use, also play a role in influencing gut microbiota. Aim: This narrative review summarizes how three distinct dietary types (plant-based, Mediterranean, and Western) affect the composition of gut microbiota and the development of non-communicable diseases (NCDs). Methods: A comprehensive literature search was conducted using the PubMed, Web of Science, and Scopus databases, focusing on the keywords “dietary pattern”, “gut microbiota” and “dysbiosis”. Results: Both plant-based and Mediterranean diets have been shown to promote the production of beneficial bacterial metabolites, such as short-chain fatty acids (SCFAs), while simultaneously lowering concentrations of trimethylamine-N-oxide (TMAO), a molecule associated with negative health outcomes. Additionally, they have a positive impact on microbial diversity and therefore are generally considered healthy dietary types. On the other hand, the Western diet is a typical example of an unhealthy nutritional approach leading to an overgrowth of pathogenic bacteria, where TMAO levels rise and SCFA production drops due to gut dysbiosis. Conclusion: The current scientific literature consistently highlights the superiority of plant-based and Mediterranean dietary types over the Western diet in promoting gut health and preventing NCDs. Understanding the influence of diet on gut microbiota modulation may pave the way for novel therapeutic strategies.

1. Introduction

The gut microbiota is a dynamic complex of microorganisms located in the gastrointestinal tract of humans [1]. It includes Bacteria, Archaea, viruses, and protists, most of which engage in a symbiotic relationship with the host. However, certain conditions can turn commensal bacteria into parasites [2,3]. As a pivotal part of the human body, gut microbiota plays a significant role in nutrition and physiology [4]. It is often suggested to be a superorganism [5]. So far, over 2000 species have been identified, with 12 distinct phyla. The majority of isolated species, 93.5% were Proteobacteria, Actinobacteria, Firmicutes, and Bacteroidetes [6]. Firmicutes make up 65% of the total gut bacteria, Bacteroidetes 23%, Actinobacteria 5%, and the fourth most represented phyla are Proteobacteria [7].
Diet is a fundamental factor for maintaining healthy status and preventing non-communicable diseases (NCDs), such as cancer, cardiovascular diseases, and cognitive or metabolic impairments. NCDs represent the majority of cases of mortality all around the world. The gut microbiota is essential in the absorption and extraction of nutrients. It is thus well known that diet has a great influence on its formation, which participates in the pathogenesis of NCDs [8,9,10]. The gut microbiota closely interacts with the immune system and metabolism. Changes in a diet not only affect the gut bacteria but also have an impact on bodily functions. For instance, the gut microbiota plays a role in responding to infections or regulating the appetite, as some microbial products influence the hypothalamic satiety pathway. A shift in microbial equilibrium caused by dietary changes leads to dysbiosis, which is related to many disorders. Therefore, a balanced diet with antioxidant and anti-inflammatory components represents a valuable way to prevent multiple NCDs [5,7].
Both macronutrients, such as fiber, protein, and fatty acids, and micronutrients, including minerals and vitamins, significantly impact gut microbiota diversity and composition. Both long-term and short-term dietary interventions have proven to be effective. For instance, a diet high in fiber may lengthen the lifespan by reducing systemic inflammation, a result of fiber fermentation by-products. Rural communities tend to have more diverse gut microbiota, which is linked to their high fiber consumption and enhanced Bacterial capacity for fiber fermentation. Similar health benefits have been seen in individuals following a diet rich in whole grains and total carbohydrates. In comparison, diets rich in fats and low in fiber, such as the Western diet, are associated with increased inflammation levels. The Westernization of a diet also reduces bacterial diversity, and some bacteria may even be absent compared to rural populations [5,11,12].
Nutritional content differs among various dietary patterns. However, focusing on a single nutrient is not ideal for determining the impact of a diet on an individual. Consequently, studying dietary patterns is more appropriate, as they provide better information about various interactions between nutrients, both synergistic and antagonistic. Synergistic food interactions between food components and dietary patterns have a profound effect on overall health. Current evidence suggests that despite the fact that some nutrients might have an impact on the prevention of chronic disorders, no isolated component is protective. This is due to the complexity of food acting on various biochemical pathways, which is especially relevant for chronic diseases such as cancer, cardiovascular diseases, obesity, and type 2 diabetes. In addition, paying attention only to nutrients might also have contradictory outcomes. For example, a diet rich in saturated fats is linked to a higher risk of cardiovascular diseases. However, diets high in carbohydrates and low in fats can lead to an overconsumption of added sugars and refined carbohydrates, further multiplying the cardiovascular risk [13,14].
The aim of this narrative review is to assess the relationship between three dietary types (plant-based diet, Mediterranean diet, and Western diet) and the bacterial composition of the gut. Furthermore, we evaluate the impact of gut dysbiosis on the development of NCDs.

2. Methods

This review employs a narrative approach to analyze publications in the field and to highlight the importance of different dietary patterns and their effects on gut microbiota composition, as well as the development of diseases related to gut microbiota. This narrative review was conducted using the PubMed, Web of Science, and Scopus databases for a literature search, with an emphasis on the keywords “dietary pattern”, “gut microbiota” and “dysbiosis”. The inclusion criteria were limited to English-language papers related to gut microbiota and the development of chronic diseases. The emphasis was placed on empirical studies as well as on systematic reviews that systematize state-of-the-art knowledge. Abstracts and full texts were independently reviewed by two authors, ensuring that the articles meet the selection criteria for this topic. All duplicates were removed, resulting in a final selection of 120 articles, written in English between 2005 and 2024, for inclusion in the narrative review.

3. Gut Microbiota Composition in the Gastrointestinal Tract

The distribution, quantity, and type of microorganisms vary throughout the gastrointestinal tract. While relatively few species inhabit the stomach and small intestine, the large intestine is home to a dense and diverse microbial community [15]. This is due to different physiology, pH, accessibility of substrates, oxygen partial pressure, flow rate of digestion, and host secretions [16]. At least 700 different bacterial species are present in the human mouth cavity [17]. More than 94% comprises six phyla, Bacteroidetes, Firmicutes, Fusobacteria, Actinobacteria, Proteobacteria, and Spirochaetes. The distribution of bacteria is modified by saliva and soft- and hard-tissue surfaces. More essentially, the hard surface of the tooth enables the formation of biofilms, which establish a steady environment for bacterial growth [18]. In the esophagus, the most abundant genus is Streptococcus [19]. It is suggested that healthy stomach microbiota is mostly formed by Prevotella, Veillonella, Streptococcus, Haemophilus, and Rothia. In addition, Bacteroidetes, Firmicutes, Fusobacteria, Actinobacteria, and Proteobacteria were also found [20]. People who tested positive for Helicobacter pylori had this bacterium as the most represented. However, the presence of Helicobacter pylori does not affect the microbial diversity of the stomach [21].
The small intestine is divided into three sections: duodenum, jejunum, and ileum. The main function that the small intestine serves is the absorption of nutrients [22]. The microbiota is less diverse and numerous than in the colon, with a biological mass of 103–107 microbial cells per gram of intestinal tissue, mainly because of lower pH, pancreatic peptides, bile acids, and quicker transit time. It is assumed that the most abundant phyla are Proteobacteria and Firmicutes, which can withstand these factors [23]. Other frequently occurring bacteria are Veillonella and Streptococcus [22]. The large intestine comprises multiple parts, namely, the caecum, ascending, transverse, descending, sigmoid colon, and rectum. Anaerobic conditions of the large intestine provide a good environment for anaerobic microorganisms to grow [24]. The most represented bacterial phyla are Bacteroidetes and Firmicutes, which together make up 90% of the total bacteria population [25]. During life, the ratio between Bacteroidetes and Firmicutes varies, which can implicate the health of an individual. In terms of density, dominant bacterial genera, Bacteroides, Bifidobacterium, Eubacterium, Clostridium, Propionibacterium, Peptostreptococcus, and Ruminococcus, account for 109 of bacterial cells/gram of colon tissue [26]. There are also pathogenic bacteria present in the large intestine, namely, Escherichia coli, Vibrio cholerae, Bacteroides fragilis, Salmonella enterica and Campylobacter jejuni, and they form around 0.1% of the total bacterial population [27].

4. Function of Gut Microbiota

The gut microbiota plays a critical role in the fermentation of dietary fiber (oligosaccharides, polysaccharides, pectin, lignin, and resistant starches). By doing so, it generates short-chain fatty acids (SCFAs), namely, acetate, butyrate, and propionate. The main bacterial phyla involved in SCFA production are Firmicutes and Bacteroidetes [28,29]. SCFAs are absorbed in the gastrointestinal tract (GIT) and represent a valuable source of energy for host cells [30]. SCFAs also have a variety of different effects, for example, regulation of gene expression, apoptosis, chemotaxis, activation of gluconeogenesis, and possibly regulation of appetite or maintaining the integrity of the GIT epithelium [31,32,33]. Acetate was reported to be involved in the production of IgA by intestinal B-cells and IgA plays a crucial role in the toleration of gut bacteria and fight against pathogenic bacteria [34].
By metabolizing lecithin, choline, and L-carnitine by gut bacteria, a trimethylamine (TMA) is formed. TMA is then oxidated in the liver, and TMA changes into trimethylamine-N-oxide (TMAO), a molecule with proatherogenic effects [35]. TMA is produced mainly by Proteobacteria, Actinobacteria, and Firmicutes phyla [36]. Additionally, gut bacteria synthesize essential vitamins, including vitamin K and several B-group vitamins, such as folate, which is crucial for DNA synthesis and repair. Folate is synthesized mostly by Bifidobacteria [37,38]. Furthermore, gut bacteria can break down primary bile acids, transforming them into secondary bile acids, which can be reabsorbed [39]. The gut microbiota is also associated with the activation of polyphenols. After the activation, polyphenols are absorbed in the portal system [40].
Research has revealed a connection between the gut microbiota and the brain. The gut–brain axis is a bidirectional communication network that links the central, autonomic, and enteric nervous system with the hypothalamic pituitary adrenal system. This axis is believed to influence multiple mechanisms, including satiety and digestive functions, as well as behavior and mood [41,42]. There are multiple pathways between the brain and the gut, neural, endocrine, and immunological. The vagus nerve and ENS mediate the neural pathway. The ENS comprises the Meissner’s plexus found in the intestinal submucosa and the Auerbach’s plexus in the muscular layer of the intestine. The ENS is not only interconnected by many neural fibers but is also closely linked with gut-associated lymphoid tissue (GALT). Endocrine pathways involve the production of various molecules by gut bacteria, such as serotonin, acetylcholine, dopamine, or gamma-aminobutyric acid (GABA). In terms of the immune system’s role in the gut–brain axis, pro-inflammatory cytokines have a toxic effect on the central nervous system (CNS). The synthesis of the pro-inflammatory cytokines can be induced by lipopolysaccharide (LPS), a structural part of Gram-negative bacteria [43].

5. Factors Influencing the Gut Microbiota

The gut microbiota is at early stages of life influenced by the mother’s microbiota, but various factors shape it later in life, for instance, infections, the immune system, diet, and the use of medication. Genetics play an essential role in the formation of gut microbiota and several bacterial species are heritable, such as Actinobacteria and Firmicutes. This can be demonstrated in monozygotic and dizygotic twins. Both types of twins, when sharing the same environment, show differences, but the difference between the gut microbiota of monozygotic twins is smaller [44]. Age is another important factor in gut microbiota composition. In infants, the gut microbiota lacks diversity when compared to adults. There is a large influx of bacteria until about 3 years of age when the gut microbiota starts to develop adult characteristics as the diet transitions from milk to solid foods [45,46]. In adult humans, the structure and function of gut microbiota stay stable, but events such as diseases and antibiotic treatments may cause an alteration by changing bacterial composition and transferring genes of antibiotic resistance [1,47,48]. In the elderly population (over 65 years old), bacterial diversity decreases and there is a shift towards facultative anaerobic bacteria at the expense of beneficial bacteria [49].
Lifestyle factors, including alcohol consumption, smoking, and physical activity, further modulate gut microbiota. Alcohol promotes dysbiosis through two mechanisms: a change in gut microbiota composition and a reduction in nutrient absorption. Smoking as a risk factor acts in many ways, for instance, by modifying pH and oxygen levels, and through the production of acid in the gastrointestinal tract. Tobacco is also an immunosuppressant. Exercise can enhance the diversity of gut microbiota and is even suggested as a remedy for dysbiosis-related chronic illnesses. However, it is difficult to prove the beneficial effects of exercise on the gut microbiota of athletes since most of them have a distinct diet [50,51,52,53,54,55,56].
Diet and geography are important factors involved in the diversity of gut microbiota [57]. When comparing industrialized and non-industrialized countries, there is a greater Bacteroidetes-to-Firmicutes ratio [55]. Another division is by using enterotypes. Three types can be distinguished: enterotype 1, characterized by an abundance of Bacteroides; enterotype 2, rich in Prevotella; and enterotype 3, where Firmicutes are large in number, especially Ruminococcus [58]. Higher altitudes suit anaerobic bacteria, and during cold environmental stress, there is a change in the Bacteroidetes-to-Firmicutes ratio in favor of Firmicutes [59,60].

6. Diseases Related to Gut Microbiota

Dysbiosis is a term that indicates the change and imbalance in the gut microbiota’s composition, which can lead to various illnesses [61]. As regards gastrointestinal diseases, for instance, irritable bowel syndrome (IBS) is characterized by altered gut–brain axis signaling, a change in the motility of GIT, increased visceral sensitivity, and impaired gut barrier function [62]. In terms of gut bacteria composition of IBS patients, the Bifidobacterium and Faecalibacterium populations were reduced. On the other hand, Proteobacteria, Bacteroides, and Lactobacillacae showed higher numbers in contrast to the control group [63]. Inflammatory bowel disease (IBD) consists of Crohn’s disease and ulcerative colitis [64]. Numerous changes in the gut microbiota of IBD patients have been reported, namely, a higher abundance of Candida tropicalis, Escherichia coli, and a decrease in Firmicutes, Bacteroidetes, or Faecalibacterium prausnitzii in comparison with the control group [55,65,66]. The pathogenesis of colorectal cancer (CRC) is characterized by a greater number of pathogenic bacteria. For example, Bacteroides fragilis and Escherichia coli promote a chronic inflammation of intestinal tissue, which can lead to the development of CRC [67].
It was believed that the Firmicutes/Bacteroidetes ratio changes during the pathogenesis of obesity; however, this has been recently proven untrue, as there is no microbiological connection to human obesity [68]. Dysbiosis of the gut microbiota is a factor connected to the pathogenesis of diabetes mellitus (DM), both type 1 and type 2 [69]. To be more specific, type 1 DM patients exhibit a higher abundance of Ruminococcus and Bacteroides, with a lower proportion of Prevotella and Clostridium as opposed to the control group. In type 2 DM, there is a drop in Akkermansia and Bifidobacterium amounts [70,71,72]. Furthermore, type 2 DM represents a good environment for the growth of opportunistic pathogens, for example, Escherichia coli or Clostridium symbiosum [73]. This growth is due to higher concentrations of pro-inflammatory cytokines. Some bacteria, like Lactobacillus, can inhibit the production of pro-inflammatory IL-1β. Similarly, Akkermasia can decrease concentrations of TNF-α, and Bifidobacterium species may even have positive effects on glucose tolerance [74]. On the other hand, Escherichia coli is enhanced in prediabetic patients, individuals with already altered glucose tolerance [75].
It is suggested that the gut–brain axis might be associated with neuroinflammation, a process that leads to the loss of neurons, which is typical for Alzheimer’s disease (AD) and Parkinson’s disease (PD). PD patients had a higher abundance of Enterobacteriaceae and reduced populations of Prevotellaceae. AD is influenced by pathogenic bacteria like Mycobacterium tuberculosis, Staphylococcus aureus, or Salmonella spp. [76,77]. The gut–brain axis also seems to be linked to the pathogenesis of depression and anxiety [42]. Autism spectrum disorder (ASD) is another neurological disability in which the dysbiosis of gut microbiota is suggested to be involved, but the evidence is conflicting [78].
In addition, gut bacteria are also affiliated with cardiovascular disorders. As already mentioned, SCFAs and TMAO are metabolites produced by gut bacteria. SCFAs seem to have beneficial antihypertensive effects [79]. Conversely, TMAO plays a role in atherosclerosis’s pathogenesis by increasing cholesterol absorption by macrophages. Another mechanism might be linked to a decrease in HDL cholesterol concentrations. Moreover, TMAO has been linked to the activation of platelets [36]. Another molecule synthesized by the gut microbiota is phenylacetylglutamine (PAG). PAG is connected to acute cardiovascular events, like stroke, heart attack, or sudden death [79].

7. The Effect of Diets on Gut Microbiota Composition

Plant-based diets primarily consist of fruits, vegetables, seeds, nuts, legumes, whole grains, and herbs [80]. There are several types of plant-based diets, each with different restrictions on certain food groups. Flexitarians, for example, rarely consume meat, while pescatarians include fish and seafood as their only sources of animal protein. Ovolactovegetarians exclude meat products but consume dairy or eggs, whereas vegans adhere to a diet entirely composed of plant-based foods [81]. The Mediterranean diet is inspired by the traditional dietary patterns of countries bordering the Mediterranean Sea. It is predominantly a plant-based diet, with olive oil serving as a main source of fat. Animal products are consumed in moderation [82,83]. Other aspects of the Mediterranean diet are adequate intake of fish and dairy products with moderate consumption of red wine, which is served only during meals [84]. Conversely, the Western diet is often regarded as an unhealthy diet due to its excessive consumption of processed and refined foods, simple sugars, sweets, and animal fats, coupled with an inadequate intake of fruits, vegetables, nuts, and whole grains [7,85,86,87]. As shown in Figure 1, plant-based and Mediterranean diets lead to an increase in SCFA levels while simultaneously decreasing TMAO production. The Firmicutes/Bacteroidetes ratio is lower, and various health benefits are associated with these dietary patterns. On the contrary, the Western diet promotes the development of multiple chronic diseases and dysbiosis and causes an increase in TMAO levels together with a drop in SCFA production (Figure 1).

7.1. Plant-Based Diet

In 2023, there was a systematic review conducted by Sidhu et al. on the influence of plant-based diets on gut microbiota composition and the benefits of such diets in managing inflammatory and metabolic disorders. They included randomized control trials, non-randomized control trials, and pre–post interventions that explored the impact of a plant-based diet on gut microbiota. The systematic review analyzed 12 interventional studies, incorporating data from a total of 583 participants, aged 21 to 61 years, including both men and women. Participants varied in health status, comprising healthy individuals, those with obesity, rheumatoid arthritis, and individuals at cardiovascular risk. They adhered to a plant-based diet for periods ranging from 5 days to 13 months. A higher abundance of Ruminococcaceae and a decreased population of Bacteroidaceae were revealed in individuals following plant-based diets. Notably, differences were observed between vegan and vegetarian diets: vegans exhibited higher levels of Coprococcus and Faecalibacterium, while these bacterial populations were reduced in vegetarians. Additionally, improvements were noted in patients with rheumatoid arthritis and those with cardiovascular disorders, with optimized lipid profiles and blood pressure levels. These positive outcomes may be attributed to metabolic products like SCFAs or TMAO [88]. SCFAs, which are produced by the degradation of dietary fibers and carbohydrates, play an important role in the immune, metabolic, and neural systems [32]. The consumption of vegetables and fruits significantly influences SCFA levels, with a plant-based diet being shown to be superior in promoting SCFA production compared to an animal-based diet [88,89]. Conversely, an elevated TMAO level is associated with inflammation and metabolic diseases, mainly obesity and diabetes. Studies have shown that a plant-based diet can decrease TMAO levels compared to an animal-based diet [90]. In a study conducted by Djekic et al., comparing a vegetarian diet to a meat-dominant diet in patients with ischemic heart disease, a higher abundance of Akkermansiaceae, Ruminococcaceae, and Lachnospiraceae was found in subjects following the vegetarian diet. Consistent with previous findings, the vegetarian diet led to an increase in SCFA production and a decrease in TMAO levels, although this relationship was not statistically significant. However, a significant relationship between reduced plasma levels of L-carnitine (a TMAO precursor) and the vegetarian diet was demonstrated [91] (Table 1 and Table 2, Figure 1).
Trefflich et al. published a systematic review examining the relationship between gut microbiota composition and vegan or vegetarian diets compared to omnivorous diets. The review included 16 cross-sectional studies, primarily involving men and women aged 18 to 72. The total number of participants was 1229, consisting of 498 omnivores, 389 vegetarians, and 342 vegans who had adhered to a vegetarian or vegan diet for more than a month. The findings indicated that vegans had higher levels of Bacteroidetes compared to omnivores, while Firmicutes levels remained similar across the groups [110]. A study conducted by Kim et al. also addressed the Firmicutes/Bacteroidetes ratio. While obese individuals expressed a high Firmicutes/Bacteroidetes ratio, after adhering to a strict vegetarian diet, the ratio was reversed [103]. Additionally, according to Trefflich et al., vegetarians were reported to have increased levels of Actinobacteria. Among vegans, a decrease in Proteobacteria and an increase in Verrucomicrobia were found, both when compared to omnivores. Moreover, the Clostridium species quantity was substantially decreased in vegetarians compared to omnivores. However, this phenomenon was not observed in vegans, and the levels of Faecalibacterium prausnitzii were not fundamentally altered [110]. On the contrary, Kahleova et al. found that adherence to a vegan diet leads to a rise in Faecalibacterium prausnitzii populations in overweight individuals, along with a lower abundance of Bacteroides fragilis [92]. A plant-based diet also plays a role in gut microbiota composition during pregnancy. When comparing vegetarian and omnivorous pregnant women, Roseburia and Lachnospiraceae populations increased, while Collinsella and Hholdemania populations decreased [93]. Losno et al. investigated the composition of adult gut microbiota, comparing vegans and omnivores. Their results showed that Bacteroidetes were in higher numbers in vegans when compared to omnivores. Within Bacteroidetes, vegans exhibited an increase in Prevotella, but Bacteroides results were inconsistent. Furthermore, Bifidobacteria and Enterobacteria were less abundant in the vegan population than in omnivores. Interestingly, vegans also demonstrated a lower abundance of Staphylococcus, Streptococcus, and Corynebacteria compared to omnivores [111]. Raman et al. revealed different results. Individuals who followed a vegan diet and practiced meditation expressed a higher abundance of not only Bifidobacteria, but also Lactobacillus, Streptococcus, Collinsella, and Ruminococcaceae in contrast to the control group [94] (Table 1 and Table 2, Figure 1).

7.2. Mediterranean Diet

Kimble et al. assessed the effect of the Mediterranean diet on gut bacteria diversity, abundance, and metabolic products in a systematic review that evaluated 34 studies with a total of 4526 participants aged 22 to 95. While the majority of participants were healthy, individuals with various medical conditions were also included. Of the studies, 17 were observational, with 3 being prospective and 14 cross-sectional, while the other 17 were randomized control trials. Regarding bacterial diversity, a decrease in Firmicutes and an increase in Bacteroidetes populations in those who followed the Mediterranean diet were reported [82]. Similar results were described by Garcia-Mantrana, reporting that consuming a Mediterranean diet restricted in animal proteins leads to a lower Firmicutes/Bacteroidetes ratio [104]. In addition to that, following a hypocaloric Mediterranean diet reduces Firmicutes populations while increasing Bacteroidetes and Proteobacteria levels in obese individuals [95]. Kimble et al. also described a higher abundance of Faecalibacterium prausnitzii, which was also recognized in a study conducted by Meslier et al., where individuals following the Mediterranean diet displayed higher levels of Faecalibacterium prausnitzii, along with Lachnospiraceae and Roseburia [82,96] (Table 1 and Table 2, Figure 1).
Three core components of the Mediterranean diet are fiber, extra virgin olive oil (EVOO), and polyunsaturated fatty acids (PUFAs) [83]. It has been demonstrated that the consumption of EVOO leads to an expansion of Lactobacillus and reduced growth of pathogenic bacteria [112]. Similarly, PUFAs demonstrated anti-inflammatory and cardioprotective properties, with omega-3 (ω-3) PUFAs promoting the growth of Bifidobacterium while having an opposing effect on Faecalibacterium populations [7,113]. Dietary fiber is metabolized by gut bacteria, leading to the synthesis of SCFAs, which possess anticancer and cardioprotective properties [83]. Among SCFAs, a rise in propionate and butyrate is particularly notable in individuals following the Mediterranean diet, as observed in a study conducted by Seethaler et al. [106]. Similarly to a plant-based diet, TMAO levels are also decreased [108]. In addition, this diet has been shown to lower the risk of developing diabetes mellitus and other metabolic disorders [114]. So et al. conducted a systematic review and a meta-analysis where they analyzed the impact of dietary fiber on the composition of gut microbiota. While they did not identify any changes in alpha diversity, they did observe an increase in Bifidobacterium and Lactobacillus [115]. Other beneficial effects are attributed to a decreased oxidative state, inflammation, and positive impact on metabolic health represented by increased levels of Eubacterium rectale and Clostridium leptum, bacteria producing short-chain fatty acids, raising the levels of Bacteroides, Bifidobacteria, and Faecalibacterium prausnitzii species, and lowering the levels of Blautia species and Firmicutes [116]. However, a study by Rinott at al. noted reduced levels of Bifidobacterium, along with a higher Prevotella abundance after following the Mediterranean and Green Mediterranean diets [97]. Conversely, in previous observations, Diamanti et al. reported a drop in Lactobacillaceae and Prevotella copri populations in rheumatoid arthritis patients who showed greater adherence to the Mediterranean diet [98]. Additionally, Zhu et al. further explored the effect of a fiber-rich diet on gut microbiota. Their findings revealed improved microbial evenness and an increase in certain beneficial genera within the Firmicutes phylum. They also noted a positive effect of the fiber-rich diet on retrospective memory [117]. The Mediterranean diet is also rich in minerals, such as iron and zinc, both of which have an indisputable impact on overall health, including the activation of the immune system. However, iron can also promote the growth of pathogenic gut bacteria, leading to increased inflammation. The Bifidobacteriacae family can interact with iron by binding to it, therefore minimizing the negative effects of iron [7] (Table 1 and Table 2, Figure 1).

7.3. Western Diet

The health consequences of the Western diet are extensive, such as dyslipidemia, insulin resistance, systemic inflammation, overactivation of sympathetic and renin-angiotensin systems, as well as alterations in gut microbiota [87]. A major effect of the Western diet on the gut microbiota stems from the high consumption of processed and ultra-processed foods. Research has shown that factors such as acellular nutrients, artificial sweeteners, and emulsifiers can harm the gut microbiota and thus promote dysbiosis [118]. Another significant component of the Western diet is the excessive consumption of fats. Wolters et al. conducted a systematic review of the impact of fat on the composition of gut microbiota. They incorporated a total of 15 studies, out of which nine were cross-sectional observational studies and six randomized control trials. The number of participants varied widely, with cross-sectional studies ranging from 9 to 531 participants, and randomized controlled trials involving between 20 and 88 participants. Of these studies, 10 included both men and women, while two included only men and three only women with participants’ mean ages ranging from 8.1 to 63.3 years. Individuals followed a high-fat diet for 3 weeks up to a year. A reduced number of bacteria was observed in individuals following a diet high in monounsaturated fatty acids (MUFAs); however, Prevotella, Enterobacteriaceae, Parabacteroides, and Turicibacter populations grew. The ratio between Firmicutes and Bacteroidetes was also changed, with an increase in Firmicutes and decreased levels of Bacteroidetes [119]. Comparable results were presented by Nakayama et al., where children consuming a high-fat diet exhibited a higher Firmicutes/Bacteroidetes ratio [105]. Similarly, Wan et al. observed changes in gut microbiota following a high-fat diet, noting reduced levels of Faecalibacterium, while Bacteroides and Alistipes populations increased. In addition, a high-fat diet decreases the levels of specific SCFAs, including acetic acid, 2-hydroxybutyric acid, and 2-methylbutyric acid [99,107] (Table 1 and Table 2, Figure 1).
Other components of the Western diet might also affect the gut microbiota, for instance, refined carbohydrates, red and processed meat, and refined grains. Consumption of red meat leads to an increase in TMAO production. Moreover, the pathogenesis of CRC is strongly influenced by excessive consumption of red and processed meat. Gut dysbiosis may play a role in the CRC pathogenesis, namely, causing an increased volume of Escherichia coli, Streptococcus bovis, Bacteroides fragilis, and Fusobacterium nucleatum, which can create inflammation or alter the oncogenes and tumor-suppressing genes. However, Vanegas et al. found that the consumption of whole grains instead of refined grains leads to reduced numbers of pro-inflammatory Enterobacteriaceae [88,100,109,120]. Fried meat, as an unhealthy food preparation method, was shown in a study by Gao et al. to reduce gut microbiota diversity and cause alterations in bacteria abundances, including an increase in Veillonella, Dorea, and Dialister, while Flavonifractor and Lachnospiraceae levels were lower [101]. Additionally, added sugars may modulate the gut microbiota. Ramne et al. found that the consumption of sugar-sweetened beverages also adversely affects Lachnobacterium and leads to an increase in Firmicutes within the Firmicutes/Bacteroidetes ratio [102]. Furthermore, negative effects on insulin metabolism are associated with higher levels of Clostridium bolteae and Blautia, which are linked to diets high in short fatty acids (SFAs) [119]. As previously mentioned, systemic inflammation is a consequence of the Western dietary pattern. One of the main inflammation drivers is LPS. Increased gut permeability enhances the absorption of LPS, which may be attributed to a decrease in proteins that form the intestinal barrier, such as occludin and claudin [10] (Table 1 and Table 2, Figure 1).

8. Conclusions

The evidence reviewed in this article underscores the profound impact of diet on gut microbiota composition and, consequently, on health outcomes. Plant-based and Mediterranean diets, characterized by a high fiber intake and beneficial fats, are associated with enhanced production of SCFAs and reduced levels of TMAO, both of which are critical in reducing the risk of cardiovascular and metabolic diseases. These diets also promote greater microbial diversity, which is protective against a range of non-communicable diseases. In stark contrast, the Western diet, typified by high consumption of processed foods, fats, and sugars, is linked to gut dysbiosis, characterized by reduced microbial diversity, lower SCFA production, and elevated TMAO levels. This dysbiotic state significantly contributes to the development and progression of NCDs, including cardiovascular disease, obesity, diabetes, and colorectal cancer.
The current scientific literature consistently highlights the superiority of plant-based and Mediterranean dietary patterns over the Western diet in promoting gut health and preventing NCDs. However, the relationship between diet and gut microbiota is complex and influenced by numerous factors, including genetics, environment, and lifestyle. Future research should aim to deepen our understanding of these interactions and explore how targeted dietary interventions can be leveraged as therapeutic strategies to modulate gut microbiota composition and improve health outcomes. Moreover, identifying specific gut microbiota profiles associated with various health states could lead to the development of personalized nutrition approaches for the prevention and management of NCDs.

Author Contributions

M.S., J.B., B.G., and L.H. wrote the manuscript with the supervision and assistance of Ľ.A. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by a grant KEGA No. 015UK-4/2022 Innovation of education in the field of health protection and promotion with an emphasis on e-learning and implementation of multimedia technologies.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Thursby, E.; Juge, N. Introduction to the human gut microbiota. Biochem. J. 2017, 474, 1823–1836. [Google Scholar] [CrossRef] [PubMed]
  2. Rosenberg, E.; Zilber-Rosenberg, I. Microbes Drive Evolution of Animals and Plants: The Hologenome Concept. mBio 2016, 7, e01395. [Google Scholar] [CrossRef]
  3. Anhê, F.F.; Barra, N.G.; Schertzer, J.D. Glucose alters the symbiotic relationships between gut microbiota and host physiology. Am. J. Physiol. Endocrinol. Metab. 2020, 318, E111–E116. [Google Scholar] [CrossRef] [PubMed]
  4. Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T.; et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 59–65. [Google Scholar] [CrossRef]
  5. Salvucci, E. The human-microbiome superorganism and its modulation to restore health. Int. J. Food Sci. Nutr. 2019, 70, 781–795. [Google Scholar] [CrossRef] [PubMed]
  6. Hugon, P.; Dufour, J.C.; Colson, P.; Fournier, P.E.; Sallah, K.; Raoult, D. A comprehensive repertoire of prokaryotic species identified in human beings. Lancet Infect. Dis. 2015, 15, 1211–1219. [Google Scholar] [CrossRef]
  7. García-Montero, C.; Fraile-Martínez, O.; Gómez-Lahoz, A.M.; Pekarek, L.; Castellanos, A.J.; Noguerales-Fraguas, F.; Coca, S.; Guijarro, L.G.; García-Honduvilla, N.; Asúnsolo, A.; et al. Nutritional Components in Western Diet Versus Mediterranean Diet at the Gut Microbiota-Immune System Interplay. Implications for Health and Disease. Nutrients 2021, 13, 699. [Google Scholar] [CrossRef] [PubMed]
  8. Hills, R.D., Jr.; Pontefract, B.A.; Mishcon, H.R.; Black, C.A.; Sutton, S.C.; Theberge, C.R. Gut Microbiome: Profound Implications for Diet and Disease. Nutrients 2019, 11, 1613. [Google Scholar] [CrossRef] [PubMed]
  9. Cena, H.; Calder, P.C. Defining a Healthy Diet: Evidence for The Role of Contemporary Dietary Patterns in Health and Disease. Nutrients 2020, 12, 334. [Google Scholar] [CrossRef]
  10. Beam, A.; Clinger, E.; Hao, L. Effect of Diet and Dietary Components on the Composition of the Gut Microbiota. Nutrients 2021, 13, 2795. [Google Scholar] [CrossRef]
  11. Berding, K.; Vlckova, K.; Marx, W.; Schellekens, H.; Stanton, C.; Clarke, G.; Jacka, F.; Dinan, T.G.; Cryan, J.F. Diet and the Microbiota-Gut-Brain Axis: Sowing the Seeds of Good Mental Health. Adv. Nutr. 2021, 12, 1239–1285. [Google Scholar] [CrossRef] [PubMed]
  12. Wastyk, H.C.; Fragiadakis, G.K.; Perelman, D.; Dahan, D.; Merrill, B.D.; Yu, F.B.; Topf, M.; Gonzalez, C.G.; Van Treuren, W.; Han, S.; et al. Gut-microbiota-targeted diets modulate human immune status. Cell 2021, 184, 4137–4153. [Google Scholar] [CrossRef] [PubMed]
  13. Jacobs, D.R.; Tapsell, L.C.; Temple, N.J. Food Synergy: The Key to Balancing the Nutrition Research Effort. Public Health Rev. 2011, 33, 507–529. [Google Scholar] [CrossRef]
  14. Tapsell, L.C.; Neale, E.P.; Satija, A.; Hu, F.B. Foods, Nutrients, and Dietary Patterns: Interconnections and Implications for Dietary Guidelines. Adv. Nutr. 2016, 7, 445–454. [Google Scholar] [CrossRef]
  15. Walter, J.; Ley, R. The human gut microbiome: Ecology and recent evolutionary changes. Annu. Rev. Microbiol. 2011, 65, 411–429. [Google Scholar] [CrossRef]
  16. Flint, H.J.; Scott, K.P.; Louis, P.; Duncan, S.H. The role of the gut microbiota in nutrition and health. Nat. Rev. Gastroenterol. Hepatol. 2012, 9, 577–589. [Google Scholar] [CrossRef]
  17. Arweiler, N.B.; Netuschil, L. The Oral Microbiota. Adv. Exp. Med. Biol. 2016, 902, 45–60. [Google Scholar] [CrossRef]
  18. Zhang, Y.; Wang, X.; Li, H.; Ni, C.; Du, Z.; Yan, F. Human oral microbiota and its modulation for oral health. Biomed. Pharmacother. 2018, 99, 883–893. [Google Scholar] [CrossRef] [PubMed]
  19. Yang, L.; Lu, X.; Nossa, C.W.; Francois, F.; Peek, R.M.; Pei, Z. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 2009, 137, 588–597. [Google Scholar] [CrossRef]
  20. Nardone, G.; Compare, D. The human gastric microbiota: Is it time to rethink the pathogenesis of stomach diseases? United Eur. Gastroenterol. J. 2015, 3, 255–260. [Google Scholar] [CrossRef]
  21. Bik, E.M.; Eckburg, P.B.; Gill, S.R.; Nelson, K.E.; Purdom, E.A.; Francois, F.; Perez-Perez, G.; Blaser, M.J.; Relman, D.A. Molecular analysis of the bacterial microbiota in the human stomach. Proc. Natl. Acad. Sci. USA 2006, 103, 732–737. [Google Scholar] [CrossRef] [PubMed]
  22. El Aidy, S.; van den Bogert, B.; Kleerebezem, M. The small intestine microbiota, nutritional modulation and relevance for health. Curr. Opin. Biotechnol. 2015, 32, 14–20. [Google Scholar] [CrossRef] [PubMed]
  23. Martinez-Guryn, K.; Hubert, N.; Frazier, K.; Urlass, S.; Musch, M.W.; Ojeda, P.; Pierre, J.F.; Miyoshi, J.; Sontag, T.J.; Cham, C.M.; et al. Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids. Cell Host Microbe 2018, 23, 458–469. [Google Scholar] [CrossRef]
  24. Eckburg, P.B.; Bik, E.M.; Bernstein, C.N.; Purdom, E.; Dethlefsen, L.; Sargent, M.; Gill, S.R.; Nelson, K.E.; Relman, D.A. Diversity of the human intestinal microbial flora. Science 2005, 308, 1635–1638. [Google Scholar] [CrossRef] [PubMed]
  25. Arumugam, M.; Raes, J.; Pelletier, E.; Le Paslier, D.; Yamada, T.; Mende, D.R.; Fernandes, G.R.; Tap, J.; Bruls, T.; Batto, J.M.; et al. Enterotypes of the human gut microbiome. Nature 2011, 473, 174–180. [Google Scholar] [CrossRef]
  26. Mariat, D.; Firmesse, O.; Levenez, F.; Guimarăes, V.; Sokol, H.; Doré, J.; Corthier, G.; Furet, J.P. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009, 9, 123. [Google Scholar] [CrossRef]
  27. Hollister, E.B.; Gao, C.; Versalovic, J. Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology 2014, 146, 1449–1458. [Google Scholar] [CrossRef]
  28. Anderson, J.W.; Baird, P.; Davis, R.H., Jr.; Ferreri, S.; Knudtson, M.; Koraym, A.; Waters, V.; Williams, C.L. Health benefits of dietary fiber. Nutr. Rev. 2009, 67, 188–205. [Google Scholar] [CrossRef]
  29. Louis, P.; Flint, H.J. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 2017, 19, 29–41. [Google Scholar] [CrossRef]
  30. Duncan, S.H.; Belenguer, A.; Holtrop, G.; Johnstone, A.M.; Flint, H.J.; Lobley, G.E. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 2007, 73, 1073–1078. [Google Scholar] [CrossRef]
  31. Corrêa-Oliveira, R.; Fachi, J.L.; Vieira, A.; Sato, F.T.; Vinolo, M.A. Regulation of immune cell function by short-chain fatty acids. Clin. Transl. Immunol. 2016, 5, e73. [Google Scholar] [CrossRef]
  32. Morrison, D.J.; Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 2016, 7, 189–200. [Google Scholar] [CrossRef]
  33. Chambers, E.S.; Morrison, D.J.; Frost, G. Control of appetite and energy intake by SCFA: What are the potential underlying mechanisms? Proc. Nutr. Soc. 2015, 74, 328–336. [Google Scholar] [CrossRef] [PubMed]
  34. Wu, W.; Sun, M.; Chen, F.; Cao, A.T.; Liu, H.; Zhao, Y.; Huang, X.; Xiao, Y.; Yao, S.; Zhao, Q.; et al. Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. Mucosal Immunol. 2017, 10, 946–956. [Google Scholar] [CrossRef]
  35. Schoeler, M.; Caesar, R. Dietary lipids, gut microbiota, and lipid metabolism. Rev. Endocr. Metab. Disord. 2019, 20, 461–472. [Google Scholar] [CrossRef]
  36. Canyelles, M.; Borràs, C.; Rotllan, N.; Tondo, M.; Escolà-Gil, J.C.; Blanco-Vaca, F. Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? Int. J. Mol. Sci. 2023, 24, 1940. [Google Scholar] [CrossRef]
  37. LeBlanc, J.G.; Milani, C.; de Giori, G.S.; Sesma, F.; van Sinderen, D.; Ventura, M. Bacteria as vitamin suppliers to their host: A gut microbiota perspective. Curr. Opin. Biotechnol. 2013, 24, 160–168. [Google Scholar] [CrossRef] [PubMed]
  38. Pompei, A.; Cordisco, L.; Amaretti, A.; Zanoni, S.; Matteuzzi, D.; Rossi, M. Folate Production by Bifidobacteria as a Potential Probiotic Property. Appl. Environ. Microbiol. 2007, 73, 179–185. [Google Scholar] [CrossRef]
  39. Nicholson, J.K.; Holmes, E.; Kinross, J.; Burcelin, R.; Gibson, G.; Jia, W.; Pettersson, S. Host-gut microbiota metabolic interactions. Science 2012, 336, 1262–1267. [Google Scholar] [CrossRef]
  40. Marín, L.; Miguélez, E.M.; Villar, C.J.; Lombó, F. Bioavailability of dietary polyphenols and gut microbiota metabolism: Antimicrobial properties. Biomed. Res. Int. 2015, 2015, 905215. [Google Scholar] [CrossRef]
  41. Cryan, J.F.; O’Riordan, K.J.; Cowan, C.S.M.; Sandhu, K.V.; Bastiaanssen, T.F.S.; Boehme, M.; Codagnone, M.G.; Cussotto, S.; Fulling, C.; Golubeva, A.V.; et al. The Microbiota-Gut-Brain Axis. Physiol. Rev. 2019, 99, 1877–2013. [Google Scholar] [CrossRef] [PubMed]
  42. Carabotti, M.; Scirocco, A.; Maselli, M.A.; Severi, C. The gut-brain axis: Interactions between enteric microbiota, central and enteric nervous systems. Ann. Gastroenterol. 2015, 28, 203–209. [Google Scholar] [PubMed]
  43. Góralczyk-Bińkowska, A.; Szmajda-Krygier, D.; Kozłowska, E. The Microbiota-Gut-Brain Axis in Psychiatric Disorders. Int. J. Mol. Sci. 2022, 23, 11245. [Google Scholar] [CrossRef] [PubMed]
  44. Kurilshikov, A.; Wijmenga, C.; Fu, J.; Zhernakova, A. Host Genetics and Gut Microbiome: Challenges and Perspectives. Trends Immunol. 2017, 38, 633–647. [Google Scholar] [CrossRef]
  45. Voreades, N.; Kozil, A.; Weir, T.L. Diet and the development of the human intestinal microbiome. Front. Microbiol. 2014, 5, 494. [Google Scholar] [CrossRef]
  46. Koenig, J.E.; Spor, A.; Scalfone, N.; Fricker, A.D.; Stombaugh, J.; Knight, R.; Angenent, L.T.; Ley, R.E. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. USA 2011, 108, 4578–4585. [Google Scholar] [CrossRef]
  47. Iizumi, T.; Battaglia, T.; Ruiz, V.; Perez Perez, G.I. Gut Microbiome and Antibiotics. Arch. Med. Res. 2017, 48, 727–734. [Google Scholar] [CrossRef]
  48. Jandhyala, S.M.; Talukdar, R.; Subramanyam, C.; Vuyyuru, H.; Sasikala, M.; Nageshwar Reddy, D. Role of the normal gut microbiota. World J. Gastroenterol. 2015, 21, 8787–8803. [Google Scholar] [CrossRef]
  49. Salazar, N.; Valdés-Varela, L.; González, S.; Gueimonde, M.; de Los Reyes-Gavilán, C.G. Nutrition and the gut microbiome in the elderly. Gut Microbes 2017, 8, 82–97. [Google Scholar] [CrossRef]
  50. Pohl, K.; Moodley, P.; Dhanda, A.D. Alcohol’s Impact on the Gut and Liver. Nutrients 2021, 13, 3170. [Google Scholar] [CrossRef]
  51. Litwinowicz, K.; Choroszy, M.; Waszczuk, E. Changes in the composition of the human intestinal microbiome in alcohol use disorder: A systematic review. Am. J. Drug Alcohol. Abuse. 2020, 46, 4–12. [Google Scholar] [CrossRef] [PubMed]
  52. Huang, C.; Shi, G. Smoking and microbiome in oral, airway, gut and some systemic diseases. J. Transl. Med. 2019, 17, 225. [Google Scholar] [CrossRef] [PubMed]
  53. Hughes, R.L. A Review of the Role of the Gut Microbiome in Personalized Sports Nutrition. Front. Nutr. 2020, 6, 191. [Google Scholar] [CrossRef]
  54. Estaki, M.; Pither, J.; Baumeister, P.; Little, J.P.; Gill, S.K.; Ghosh, S.; Ahmadi-Vand, Z.; Marsden, K.R.; Gibson, D.L. Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions. Microbiome 2016, 4, 42. [Google Scholar] [CrossRef]
  55. Gomaa, E.Z. Human gut microbiota/microbiome in health and diseases: A review. Antonie Van. Leeuwenhoek 2020, 113, 2019–2040. [Google Scholar] [CrossRef]
  56. Mohr, A.E.; Jäger, R.; Carpenter, K.C.; Kerksick, C.M.; Purpura, M.; Townsend, J.R.; West, N.P.; Black, K.; Gleeson, M.; Pyne, D.B.; et al. The athletic gut microbiota. J. Int. Soc. Sports Nutr. 2020, 17, 24. [Google Scholar] [CrossRef]
  57. Syromyatnikov, M.; Nesterova, E.; Gladkikh, M.; Smirnova, Y.; Gryaznova, M.; Popov, V. Characteristics of the Gut Bacterial Composition in People of Different Nationalities and Religions. Microorganisms 2022, 10, 1866. [Google Scholar] [CrossRef]
  58. Costea, P.I.; Hildebrand, F.; Arumugam, M.; Bäckhed, F.; Blaser, M.J.; Bushman, F.D.; de Vos, W.M.; Ehrlich, S.D.; Fraser, C.M.; Hattori, M.; et al. Enterotypes in the landscape of gut microbial community composition. Nat. Microbiol. 2018, 3, 8–16. [Google Scholar] [CrossRef] [PubMed]
  59. Adak, A.; Maity, C.; Ghosh, K.; Pati, B.R.; Mondal, K.C. Dynamics of predominant microbiota in the human gastrointestinal tract and change in luminal enzymes and immunoglobulin profile during high-altitude adaptation. Folia Microbiol. 2013, 58, 523–528. [Google Scholar] [CrossRef]
  60. Chevalier, C.; Stojanović, O.; Colin, D.J.; Suarez-Zamorano, N.; Tarallo, V.; Veyrat-Durebex, C.; Rigo, D.; Fabbiano, S.; Stevanović, A.; Hagemann, S.; et al. Gut Microbiota Orchestrates Energy Homeostasis during Cold. Cell 2015, 163, 1360–1374. [Google Scholar] [CrossRef]
  61. Shreiner, A.B.; Kao, J.Y.; Young, V.B. The gut microbiome in health and disease. Curr. Opin. Gastroenterol. 2015, 31, 69–75. [Google Scholar] [CrossRef]
  62. Bhattarai, Y.; Muniz Pedrogo, D.A.; Kashyap, P.C. Irritable bowel syndrome: A gut microbiota-related disorder? Am. J. Physiol. Gastrointest. Liver Physiol. 2017, 312, G52–G62. [Google Scholar] [CrossRef] [PubMed]
  63. Pittayanon, R.; Lau, J.T.; Yuan, Y.; Leontiadis, G.I.; Tse, F.; Surette, M.; Moayyedi, P. Gut Microbiota in Patients With Irritable Bowel Syndrome—A Systematic Review. Gastroenterology 2019, 157, 97–108. [Google Scholar] [CrossRef] [PubMed]
  64. Fabián, O.; Kamaradová, K. Morphology of inflammatory bowel diseases (IBD). Morfologie zánětlivých střevních onemocnění (IBD). Cesk Patol. 2022, 58, 27–37. [Google Scholar]
  65. Lane, E.R.; Zisman, T.L.; Suskind, D.L. The microbiota in inflammatory bowel disease: Current and therapeutic insights. J. Inflamm. Res. 2017, 10, 63–73. [Google Scholar] [CrossRef]
  66. Pittayanon, R.; Lau, J.T.; Leontiadis, G.I.; Tse, F.; Yuan, Y.; Surette, M.; Moayyedi, P. Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review. Gastroenterology 2020, 158, 930–946. [Google Scholar] [CrossRef] [PubMed]
  67. Quaglio, A.E.V.; Grillo, T.G.; De Oliveira, E.C.S.; Di Stasi, L.C.; Sassaki, L.Y. Gut microbiota, inflammatory bowel disease and colorectal cancer. World J. Gastroenterol. 2022, 28, 4053–4060. [Google Scholar] [CrossRef] [PubMed]
  68. Walker, A.W.; Hoyles, L. Human microbiome myths and misconceptions. Nat. Microbiol. 2023, 8, 1392–1396. [Google Scholar] [CrossRef]
  69. DeGruttola, A.K.; Low, D.; Mizoguchi, A.; Mizoguchi, E. Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflamm. Bowel Dis. 2016, 22, 1137–1150. [Google Scholar] [CrossRef]
  70. Zhou, H.; Zhao, X.; Sun, L.; Liu, Y.; Lv, Y.; Gang, X.; Wang, G. Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review. Dis. Markers 2020, 2020, 3936247. [Google Scholar] [CrossRef]
  71. Li, Q.; Chang, Y.; Zhang, K.; Chen, H.; Tao, S.; Zhang, Z. Implication of the gut microbiome composition of type 2 diabetic patients from northern China. Sci. Rep. 2020, 10, 5450. [Google Scholar] [CrossRef]
  72. Chen, Y.; Zhou, J.; Wang, L. Role and Mechanism of Gut Microbiota in Human Disease. Front. Cell Infect. Microbiol. 2021, 11, 625913. [Google Scholar] [CrossRef]
  73. Qin, J.; Li, Y.; Cai, Z.; Li, S.; Zhu, J.; Zhang, F.; Liang, S.; Zhang, W.; Guan, Y.; Shen, D.; et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490, 55–60. [Google Scholar] [CrossRef] [PubMed]
  74. Gurung, M.; Li, Z.; You, H.; Rodrigues, R.; Jump, D.B.; Morgan, A.; Shulzhenko, N. Role of gut microbiota in type 2 diabetes pathophysiology. eBioMedicine 2020, 51, 102590. [Google Scholar] [CrossRef]
  75. Zhou, Z.; Sun, B.; Yu, D.; Zhu, C. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus. Front. Cell Infect. Microbiol. 2022, 12, 834485. [Google Scholar] [CrossRef]
  76. Westfall, S.; Lomis, N.; Kahouli, I.; Dia, S.Y.; Singh, S.P.; Prakash, S. Microbiome, probiotics, and neurodegenerative diseases: Deciphering the gut-brain axis. Cell Mol. Life Sci. 2017, 74, 3769–3787. [Google Scholar] [CrossRef]
  77. Megur, A.; Baltriukienė, D.; Bukelskienė, V.; Burokas, A. The Microbiota-Gut-Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame? Nutrients 2020, 13, 37. [Google Scholar] [CrossRef]
  78. Fattorusso, A.; Di Genova, L.; Dell’Isola, G.B.; Mencaroni, E.; Esposito, S. Autism Spectrum Disorders and the Gut Microbiota. Nutrients 2019, 11, 521. [Google Scholar] [CrossRef]
  79. Witkowski, M.; Weeks, T.L.; Hazen, S.L. Gut Microbiota and Cardiovascular Disease. Circ. Res. 2020, 127, 553–570. [Google Scholar] [CrossRef]
  80. Ostfeld, R.J. Definition of a plant-based diet and overview of this special issue. J. Geriatr. Cardiol. 2017, 14, 315. [Google Scholar] [CrossRef]
  81. Hargreaves, S.M.; Raposo, A.; Saraiva, A.; Zandonadi, R.P. Vegetarian Diet: An Overview through the Perspective of Quality of Life Domains. Int. J. Environ. Res. Public Health 2021, 18, 4067. [Google Scholar] [CrossRef] [PubMed]
  82. Kimble, R.; Gouinguenet, P.; Ashor, A.; Stewart, C.; Deighton, K.; Matu, J.; Griffiths, A.; Malcomson, F.C.; Joel, A.; Houghton, D.; et al. Effects of a Mediterranean diet on the gut microbiota and microbial metabolites: A systematic review of randomized controlled trials and observational studies. Crit. Rev. Food Sci. Nutr. 2023, 63, 8698–8719. [Google Scholar] [CrossRef] [PubMed]
  83. Merra, G.; Noce, A.; Marrone, G.; Cintoni, M.; Tarsitano, M.G.; Capacci, A.; De Lorenzo, A. Influence of Mediterranean Diet on Human Gut Microbiota. Nutrients 2020, 13, 7. [Google Scholar] [CrossRef] [PubMed]
  84. Baliou, S.; Ioannou, P.; Apetroaei, M.-M.; Vakonaki, E.; Fragkiadaki, P.; Kirithras, E.; Tzatzarakis, M.N.; Arsene, A.L.; Docea, A.O.; Tsatsakis, A. The Impact of the Mediterranean Diet on Telomere Biology: Implications for Disease Management—A Narrative Review. Nutrients 2024, 16, 2525. [Google Scholar] [CrossRef] [PubMed]
  85. Carrera-Bastos, P.; Fontes-Villalba, M.; O’Keefe, J.H.; Lindeberg, S.; Cordain, L. The Western diet and lifestyle and diseases of civilization. Res. Rep. Clin. Cardiol. 2011, 2, 15–35. [Google Scholar] [CrossRef]
  86. Varlamov, O. Western-style diet, sex steroids, and metabolism. Biochim. Biophys. Acta Mol. Basis Dis. 2017, 1863, 1147–1155. [Google Scholar] [CrossRef]
  87. Malesza, I.J.; Malesza, M.; Walkowiak, J.; Mussin, N.; Walkowiak, D.; Aringazina, R.; Bartkowiak-Wieczorek, J.; Mądry, E. High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review. Cells 2021, 10, 3164. [Google Scholar] [CrossRef]
  88. Sidhu, S.R.K.; Kok, C.W.; Kunasegaran, T.; Ramadas, A. Effect of Plant-Based Diets on Gut Microbiota: A Systematic Review of Interventional Studies. Nutrients 2023, 15, 1510. [Google Scholar] [CrossRef]
  89. David, L.A.; Maurice, C.F.; Carmody, R.N.; Gootenberg, D.B.; Button, J.E.; Wolfe, B.E.; Ling, A.V.; Devlin, A.S.; Varma, Y.; Fischbach, M.A.; et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505, 559–563. [Google Scholar] [CrossRef]
  90. Crimarco, A.; Springfield, S.; Petlura, C.; Streaty, T.; Cunanan, K.; Lee, J.; Fielding-Singh, P.; Carter, M.M.; Topf, M.A.; Wastyk, H.C.; et al. A randomized crossover trial on the effect of plant-based compared with animal-based meat on trimethylamine-N-oxide and cardiovascular disease risk factors in generally healthy adults: Study With Appetizing Plantfood-Meat Eating Alternative Trial (SWAP-MEAT). Am. J. Clin. Nutr. 2020, 112, 1188–1199. [Google Scholar] [CrossRef]
  91. Djekic, D.; Shi, L.; Brolin, H.; Carlsson, F.; Särnqvist, C.; Savolainen, O.; Cao, Y.; Bäckhed, F.; Tremaroli, V.; Landberg, R.; et al. Effects of a Vegetarian Diet on Cardiometabolic Risk Factors, Gut Microbiota, and Plasma Metabolome in Subjects With Ischemic Heart Disease: A Randomized, Crossover Study. J. Am. Heart Assoc. 2020, 9, 016518. [Google Scholar] [CrossRef]
  92. Kahleova, H.; Rembert, E.; Alwarith, J.; Yonas, W.N.; Tura, A.; Holubkov, R.; Agnello, M.; Chutkan, R.; Barnard, N.D. Effects of a Low-Fat Vegan Diet on Gut Microbiota in Overweight Individuals and Relationships with Body Weight, Body Composition, and Insulin Sensitivity. A Randomized Clinical Trial. Nutrients 2020, 12, 2917. [Google Scholar] [CrossRef] [PubMed]
  93. Barrett, H.L.; Gomez-Arango, L.F.; Wilkinson, S.A.; McIntyre, H.D.; Callaway, L.K.; Morrison, M.; Dekker Nitert, M. A Vegetarian Diet Is a Major Determinant of Gut Microbiota Composition in Early Pregnancy. Nutrients 2018, 10, 890. [Google Scholar] [CrossRef]
  94. Raman, M.; Vishnubhotla, R.; Ramay, H.R.; Gonçalves, M.C.B.; Shin, A.S.; Pawale, D.; Subramaniam, B.; Sadhasivam, S. Isha yoga practices, vegan diet, and participation in Samyama meditation retreat: Impact on the gut microbiome & metabolome—A non-randomized trial. BMC Complement. Med. Ther. 2023, 23, 107. [Google Scholar] [CrossRef]
  95. Pisanu, S.; Palmas, V.; Madau, V.; Casula, E.; Deledda, A.; Cusano, R.; Uva, P.; Vascellari, S.; Boi, F.; Loviselli, A.; et al. Impact of a Moderately Hypocaloric Mediterranean Diet on the Gut Microbiota Composition of Italian Obese Patients. Nutrients 2020, 12, 2707. [Google Scholar] [CrossRef] [PubMed]
  96. Meslier, V.; Laiola, M.; Roager, H.M.; De Filippis, F.; Roume, H.; Quinquis, B.; Giacco, R.; Mennella, I.; Ferracane, R.; Pons, N.; et al. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut 2020, 69, 1258–1268. [Google Scholar] [CrossRef]
  97. Rinott, E.; Meir, A.Y.; Tsaban, G.; Zelicha, H.; Kaplan, A.; Knights, D.; Tuohy, K.; Scholz, M.U.; Koren, O.; Stampfer, M.J.; et al. The effects of the Green-Mediterranean diet on cardiometabolic health are linked to gut microbiome modifications: A randomized controlled trial. Genome Med. 2022, 14, 29. [Google Scholar] [CrossRef]
  98. Picchianti Diamanti, A.; Panebianco, C.; Salerno, G.; Di Rosa, R.; Salemi, S.; Sorgi, M.L.; Meneguzzi, G.; Mariani, M.B.; Rai, A.; Iacono, D.; et al. Impact of Mediterranean Diet on Disease Activity and Gut Microbiota Composition of Rheumatoid Arthritis Patients. Microorganisms 2020, 8, 1989. [Google Scholar] [CrossRef]
  99. Wan, Y.; Wang, F.; Yuan, J.; Li, J.; Jiang, D.; Zhang, J.; Li, H.; Wang, R.; Tang, J.; Huang, T. Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: A 6-month randomized controlled-feeding trial. Gut 2019, 68, 1417–1429. [Google Scholar] [CrossRef]
  100. Vanegas, S.M.; Meydani, M.; Barnett, J.B.; Goldin, B.; Kane, A.; Rasmussen, H.; Brown, C.; Vangay, P.; Knights, D.; Jonnalagadda, S. Substituting whole grains for refined grains in a 6-wk randomized trial has a modest effect on gut microbiota and immune and inflammatory markers of healthy adults. Am. J. Clin. Nutr. 2017, 105, 635–650. [Google Scholar] [CrossRef]
  101. Gao, J.; Guo, X.; Wei, W.; Li, R.; Hu, K.; Liu, X.; Jiang, W.; Liu, S.; Wang, W.; Sun, H.; et al. The Association of Fried Meat Consumption With the Gut Microbiota and Fecal Metabolites and Its Impact on Glucose Homoeostasis, Intestinal Endotoxin Levels, and Systemic Inflammation: A Randomized Controlled-Feeding Trial. Diabetes Care 2021, 44, 1970–1979. [Google Scholar] [CrossRef] [PubMed]
  102. Ramne, S.; Brunkwall, L.; Ericson, U.; Gray, N.; Kuhnle, G.G.C.; Nilsson, P.M.; Orho-Melander, M.; Sonestedt, E. Gut microbiota composition in relation to intake of added sugar, sugar-sweetened beverages and artificially sweetened beverages in the Malmö Offspring Study. Eur. J. Nutr. 2021, 60, 2087–2097. [Google Scholar] [CrossRef] [PubMed]
  103. Kim, M.S.; Hwang, S.S.; Park, E.J.; Bae, J.W. Strict vegetarian diet improves the risk factors associated with metabolic diseases by modulating gut microbiota and reducing intestinal inflammation. Environ. Microbiol. Rep. 2013, 5, 765–775. [Google Scholar] [CrossRef]
  104. Garcia-Mantrana, I.; Selma-Royo, M.; Alcantara, C.; Collado, M.C. Shifts on Gut Microbiota Associated to Mediterranean Diet Adherence and Specific Dietary Intakes on General Adult Population. Front. Microbiol. 2018, 9, 890. [Google Scholar] [CrossRef]
  105. Nakayama, J.; Yamamoto, A.; Palermo-Conde, L.A.; Higashi, K.; Sonomoto, K.; Tan, J.; Lee, Y.K. Impact of Westernized Diet on Gut Microbiota in Children on Leyte Island. Front. Microbiol. 2017, 8, 197. [Google Scholar] [CrossRef]
  106. Seethaler, B.; Nguyen, N.K.; Basrai, M.; Kiechle, M.; Walter, J.; Delzenne, N.M.; Bischoff, S.C. Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: Data from the randomized controlled LIBRE trial. Am. J. Clin. Nutr. 2022, 116, 928–942. [Google Scholar] [CrossRef] [PubMed]
  107. Brignardello, J.; Fountana, S.; Posma, J.M.; Chambers, E.S.; Nicholson, J.K.; Wist, J.; Frost, G.; Garcia-Perez, I.; Holmes, E. Characterization of diet-dependent temporal changes in circulating short-chain fatty acid concentrations: A randomized crossover dietary trial. Am. J. Clin. Nutr. 2022, 116, 1368–1378. [Google Scholar] [CrossRef] [PubMed]
  108. De Filippis, F.; Pellegrini, N.; Vannini, L.; Jeffery, I.B.; La Storia, A.; Laghi, L.; Serrazanetti, D.I.; Di Cagno, R.; Ferrocino, I.; Lazzi, C.; et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 2016, 65, 1812–1821. [Google Scholar] [CrossRef]
  109. Wang, Z.; Bergeron, N.; Levison, B.S.; Li, X.S.; Chiu, S.; Jia, X.; Koeth, R.A.; Li, L.; Wu, Y.; Tang, W.H.W.; et al. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. Eur. Heart J. 2019, 40, 583–594. [Google Scholar] [CrossRef]
  110. Trefflich, I.; Jabakhanji, A.; Menzel, J.; Blaut, M.; Michalsen, A.; Lampen, A.; Abraham, K.; Weikert, C. Is a vegan or a vegetarian diet associated with the microbiota composition in the gut? Results of a new cross-sectional study and systematic review. Crit. Rev. Food Sci. Nutr. 2020, 60, 2990–3004. [Google Scholar] [CrossRef]
  111. Losno, E.A.; Sieferle, K.; Perez-Cueto, F.J.A.; Ritz, C. Vegan Diet and the Gut Microbiota Composition in Healthy Adults. Nutrients 2021, 13, 2402. [Google Scholar] [CrossRef] [PubMed]
  112. Luisi, M.L.E.; Lucarini, L.; Biffi, B.; Rafanelli, E.; Pietramellara, G.; Durante, M.; Vidali, S.; Provensi, G.; Madiai, S.; Gheri, C.F.; et al. Effect of Mediterranean Diet Enriched in High Quality Extra Virgin Olive Oil on Oxidative Stress, Inflammation and Gut Microbiota in Obese and Normal Weight Adult Subjects. Front. Pharmacol. 2019, 10, 1366. [Google Scholar] [CrossRef]
  113. Costantini, L.; Molinari, R.; Farinon, B.; Merendino, N. Impact of Omega-3 Fatty Acids on the Gut Microbiota. Int. J. Mol. Sci. 2017, 18, 2645. [Google Scholar] [CrossRef] [PubMed]
  114. Martini, D. Health Benefits of Mediterranean Diet. Nutrients 2019, 11, 1802. [Google Scholar] [CrossRef]
  115. So, D.; Whelan, K.; Rossi, M.; Morrison, M.; Holtmann, G.; Kelly, J.T.; Shanahan, E.R.; Staudacher, H.M.; Campbell, K.L. Dietary fiber intervention on gut microbiota composition in healthy adults: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2018, 107, 965–983. [Google Scholar] [CrossRef]
  116. Barber, T.M.; Kabisch, S.; Pfeiffer, A.F.H.; Weickert, M.O. The Effects of the Mediterranean Diet on Health and Gut Microbiota. Nutrients 2023, 15, 2150. [Google Scholar] [CrossRef] [PubMed]
  117. Zhu, L.; Ming, Y.; Wu, M.; Zhang, X.; Wang, X.; Li, H.; Lin, Z.; Gao, F.; Zhu, Y. Effect of Fibre-Rich Diet and Rope Skipping on Memory, Executive Function, nad Gut Microbiota in Young Adults: A Randomized Controlled Trial. Mol. Nutr. Food Res. 2024, 68, e2300673. [Google Scholar] [CrossRef]
  118. Zinöcker, M.K.; Lindseth, I.A. The Western Diet-Microbiome-Host Interaction and Its Role in Metabolic Disease. Nutrients 2018, 10, 365. [Google Scholar] [CrossRef]
  119. Wolters, M.; Ahrens, J.; Romaní-Pérez, M.; Watkins, C.; Sanz, Y.; Benítez-Páez, A.; Stanton, C.; Günther, K. Dietary fat, the gut microbiota, and metabolic health—A systematic review conducted within the MyNewGut project. Clin. Nutr. 2019, 38, 2504–2520. [Google Scholar] [CrossRef]
  120. Abu-Ghazaleh, N.; Chua, W.J.; Gopalan, V. Intestinal microbiota and its association with colon cancer and red/processed meat consumption. J. Gastroenterol. Hepatol. 2021, 36, 75–88. [Google Scholar] [CrossRef]
Figure 1. Characteristics of three distinct dietary types. Abbreviations: SCFAs—short-chain fatty acids, TMAO—trimethylamine-N-oxide, CRC—colorectal cancer, PUFAs—polyunsaturated fatty acids, EVOO—extra virgin olive oil. Created in BioRender. Soldán, M. (2024) BioRender.com/a05r617 (accessed on 8 September 2024).
Figure 1. Characteristics of three distinct dietary types. Abbreviations: SCFAs—short-chain fatty acids, TMAO—trimethylamine-N-oxide, CRC—colorectal cancer, PUFAs—polyunsaturated fatty acids, EVOO—extra virgin olive oil. Created in BioRender. Soldán, M. (2024) BioRender.com/a05r617 (accessed on 8 September 2024).
Nutrients 16 03134 g001
Table 1. Effect of dietary types on gut microbiota composition.
Table 1. Effect of dietary types on gut microbiota composition.
Dietary TypeSampleStudy GroupsMain FindingsReference
Plant-based31 participants, with ischemic heart disease16 individuals followed a vegetarian diet (94% men, median age of 67 years), 15 followed a meat diet (93% men, median age of 68 years)Ruminococcaceae,
Akkermansiaceae, and Lachnospiraceae in individuals following a vegetarian diet
[91]
Plant-based168 overweight participants84 individuals followed a vegan diet (82% women, mean age of 52.9 years),
84 were in the control group (88% women, mean age of 57.5 years)
Faecalibacterium prausnitzii, and
Bacteroides fragilis in individuals
following a vegan diet
[92]
Plant-based27 pregnant women9 women followed
a vegetarian diet
(mean age of 33 years), 18 were omnivorous (mean age of 34 years)
Roseburia and
Lachnospiraceae
Collinsella and Holdemania in
vegetarian women
[93]
Plant-based288 participants265 individuals followed a vegan diet and meditation (139 women, mean age of 40.9 years), 23 were in the control group (13 men, mean age of 42 years)Bifidobacterium, Lactobacillus, Streptococcus, Collinsella, and Ruminococcaceae in individuals following a vegan diet[94]
Mediterranean69 participants23 obese individuals followed a hypocaloric MD (20 women, mean age of 53 years), 46 were normal-weight individuals (40 women, mean age of 49 years)↓ Firmicutes
Bacteroidetes and Proteobacteria in obese individuals following hypocaloric MD
[95]
Mediterranean82 overweight and obese
participants
43 individuals followed MD, 39 followed a regular diet (43 women, 39 men, mean age of 43 years)Faecalibacterium prausnitzii, Lachnospiraceae, and Roseburia in individuals following MD[96]
Mediterranean294 participants with dyslipidemia or abdominal obesity96 individuals followed healthy dietary guidelines (88% men, mean age of 51.34 years), 95 MD (87.5% men, mean age of 51.74 years), 95 Green MD (89.5% men, mean age 50.68 years)Prevotella and
Bifidobacterium in
individuals following MD and Green MD
[97]
Mediterranean60 participants with rheumatoid arthritis20 individuals adhered highly to an MD (100% women, mean age 66 years), 40 had low or moderate adherence to an MD (75% women, mean age of 59.5 years)Lactobacillaceae and Prevotella copri in individuals with higher
adherence to an MD
[98]
Western307 healthy participantsIndividuals were divided into 3 groups based on fat intake, a 1:1:1 ratio
(age between 18 and 35 years, 52% were women)
Faecalibacterium,
Bacteroides and Alistipes in individuals following a high-fat diet
[99]
Western81 participants40 individuals consumed refined grains (25 men, mean age of 54 years), 41 consumed whole grains (24 men, mean age of 55 years)Lachnospira and
Enterobacteriaceae in individuals consuming whole grains instead of
refined grains
[100]
Western117 overweight participants59 individuals ate fried meat 4 times/week (55.9% women, mean age of 21.1 years)
58 had limited intake of fried meat (53.5% women, mean age of 21.7 years)
Veillonella, Dorea, and Dialister
Flavonifractor and
Lachnospiraceae in individuals, who consumed fried meat
[101]
Western1371 participants1371 individuals consumed added sugars (577 with urinary sugar biomarker), 1086 sugar-sweetened beverages (SSBs), 1085 artificially sweetened beverages (ASBs), aged between 18 and 70 yearsLachnobacterium,
increased Firmicutes/Bacteroidetes ratio in
individuals consuming sugar-sweetened
beverages
[102]
Abbreviations and explanations: MD—Mediterranean diet, ↑—higher abundance, ↓—lower abundance.
Table 2. Firmicutes/Bacteroidetes ratio, and SCFA and TMAO production change with different dietary types.
Table 2. Firmicutes/Bacteroidetes ratio, and SCFA and TMAO production change with different dietary types.
Plant-Based DietMediterranean DietWestern Diet
Firmicutes/Bacteroidetes ratio↓ [103]↓ [104]↑ [105]
SCFA production↑ [89]↑ [106]↓ [107]
TMAO production↓ [90]↓ [108]↑ [109]
Abbreviations and explanations: SCFAs—short-chain fatty acids, TMAO—trimethylamine-N-oxide, ↑—increase, ↓—decrease.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Soldán, M.; Argalášová, Ľ.; Hadvinová, L.; Galileo, B.; Babjaková, J. The Effect of Dietary Types on Gut Microbiota Composition and Development of Non-Communicable Diseases: A Narrative Review. Nutrients 2024, 16, 3134. https://doi.org/10.3390/nu16183134

AMA Style

Soldán M, Argalášová Ľ, Hadvinová L, Galileo B, Babjaková J. The Effect of Dietary Types on Gut Microbiota Composition and Development of Non-Communicable Diseases: A Narrative Review. Nutrients. 2024; 16(18):3134. https://doi.org/10.3390/nu16183134

Chicago/Turabian Style

Soldán, Martin, Ľubica Argalášová, Lucia Hadvinová, Bonzel Galileo, and Jana Babjaková. 2024. "The Effect of Dietary Types on Gut Microbiota Composition and Development of Non-Communicable Diseases: A Narrative Review" Nutrients 16, no. 18: 3134. https://doi.org/10.3390/nu16183134

APA Style

Soldán, M., Argalášová, Ľ., Hadvinová, L., Galileo, B., & Babjaková, J. (2024). The Effect of Dietary Types on Gut Microbiota Composition and Development of Non-Communicable Diseases: A Narrative Review. Nutrients, 16(18), 3134. https://doi.org/10.3390/nu16183134

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop